Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
L3Harris Technologies Inc ha un obiettivo di prezzo consensuale di $274, basato sulle valutazioni degli ultimi 23 analisti. Il massimo è $323 emesso da Citigroup il luglio 25, 2025, mentre il minimo è $229 emesso da Deutsche Bank il gennaio 2, 2025. Le ultime 3 valutazioni degli analisti sono state pubblicate da Barclays, Citigroup e UBS il luglio 29, 2025, luglio 25, 2025 e luglio 25, 2025. Con un obiettivo di prezzo medio di $302.67 tra Barclays, Citigroup e UBS, c'è un cambiamento implicito del 11.11% upside per L3Harris Technologies Inc secondo queste ultime valutazioni degli analisti.
1calcolato in base alle valutazioni degli analisti
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/29/2025 | 11.97% | Barclays | $255 → $305 | Maintains | Overweight | |||
07/25/2025 | 18.58% | Citigroup | $300 → $323 | Maintains | Buy | |||
07/25/2025 | 2.79% | UBS | $262 → $280 | Maintains | Neutral | |||
07/25/2025 | 10.87% | Truist Securities | $279 → $302 | Maintains | Buy | |||
07/25/2025 | 2.79% | RBC Capital | $265 → $280 | Maintains | Sector Perform | |||
07/25/2025 | 17.47% | Susquehanna | $300 → $320 | Maintains | Positive | |||
07/25/2025 | 17.47% | Baird | $274 → $320 | Maintains | Outperform | |||
07/14/2025 | 10.13% | Citigroup | $280 → $300 | Maintains | Buy | |||
07/14/2025 | 10.13% | Susquehanna | $258 → $300 | Maintains | Positive | |||
07/11/2025 | 2.42% | Truist Securities | $260 → $279 | Maintains | Buy | |||
06/09/2025 | 2.79% | Citigroup | $245 → $280 | Maintains | Buy | |||
04/28/2025 | -17.03% | UBS | $222 → $226 | Maintains | Neutral | |||
04/25/2025 | -4.55% | Truist Securities | $264 → $260 | Maintains | Buy | |||
04/17/2025 | -3.08% | Truist Securities | $274 → $264 | Maintains | Buy | |||
04/11/2025 | -3.45% | Goldman Sachs | $198 → $263 | Upgrade | Sell → Buy | |||
04/10/2025 | -10.06% | Citigroup | $285 → $245 | Maintains | Buy | |||
04/08/2025 | -11.16% | Wells Fargo | $268 → $242 | Maintains | Overweight | |||
03/31/2025 | -8.22% | Jefferies | $260 → $250 | Maintains | Buy | |||
03/07/2025 | -1.62% | Wells Fargo | $269 → $268 | Maintains | Overweight | |||
02/26/2025 | -1.25% | Wells Fargo | $300 → $269 | Maintains | Overweight | |||
02/10/2025 | 4.63% | Citigroup | $291 → $285 | Maintains | Buy | |||
02/04/2025 | -8.22% | Morgan Stanley | $260 → $250 | Maintains | Equal-Weight | |||
02/04/2025 | -2.72% | B of A Securities | $300 → $265 | Maintains | Buy | |||
01/31/2025 | -13% | UBS | $228 → $237 | Maintains | Neutral | |||
01/31/2025 | -6.39% | JP Morgan | $265 → $255 | Maintains | Overweight | |||
01/31/2025 | -11.89% | RBC Capital | $240 → $240 | Reiterates | Sector Perform → Sector Perform | |||
01/31/2025 | 0.59% | Truist Securities | $283 → $274 | Maintains | Buy | |||
01/27/2025 | -11.89% | RBC Capital | $265 → $240 | Maintains | Sector Perform | |||
01/16/2025 | -2.72% | JP Morgan | $270 → $265 | Maintains | Overweight | |||
01/14/2025 | 3.89% | Truist Securities | $300 → $283 | Maintains | Buy | |||
01/08/2025 | -1.98% | Bernstein | $289 → $267 | Upgrade | Market Perform → Outperform | |||
01/08/2025 | -5.29% | Susquehanna | $300 → $258 | Maintains | Positive | |||
01/06/2025 | -6.39% | Barclays | $290 → $255 | Maintains | Overweight | |||
01/02/2025 | -15.93% | Deutsche Bank | $250 → $229 | Maintains | Hold | |||
01/02/2025 | — | Raymond James | — | Downgrade | Outperform → Market Perform | |||
12/11/2024 | 5.36% | Wells Fargo | $295 → $287 | Maintains | Overweight | |||
11/26/2024 | 10.13% | Argus Research | → $300 | Upgrade | Hold → Buy | |||
10/31/2024 | 10.13% | B of A Securities | $240 → $300 | Upgrade | Neutral → Buy | |||
10/28/2024 | 8.3% | Wells Fargo | $260 → $295 | Maintains | Overweight | |||
10/28/2024 | -2.72% | RBC Capital | $240 → $265 | Maintains | Sector Perform | |||
10/28/2024 | 10.13% | Truist Securities | $293 → $300 | Maintains | Buy | |||
10/18/2024 | 7.56% | Truist Securities | $250 → $293 | Maintains | Buy | |||
10/10/2024 | 6.83% | Citigroup | $268 → $291 | Maintains | Buy | |||
10/10/2024 | 10.13% | Wolfe Research | → $300 | Upgrade | Peer Perform → Outperform | |||
10/03/2024 | -8.22% | Deutsche Bank | $252 → $250 | Maintains | Hold | |||
08/14/2024 | -11.89% | RBC Capital | $250 → $240 | Downgrade | Outperform → Sector Perform | |||
08/09/2024 | -5.65% | Morgan Stanley | $275 → $257 | Downgrade | Overweight → Equal-Weight | |||
07/31/2024 | -4.55% | Wells Fargo | $262 → $260 | Maintains | Overweight | |||
07/30/2024 | -2.72% | Barclays | $245 → $265 | Maintains | Overweight | |||
07/29/2024 | -8.22% | RBC Capital | $250 → $250 | Reiterates | Outperform → Outperform | |||
07/29/2024 | -0.88% | Susquehanna | $260 → $270 | Maintains | Positive | |||
07/26/2024 | -5.65% | Deutsche Bank | $245 → $257 | Downgrade | Buy → Hold | |||
05/07/2024 | -10.06% | Wells Fargo | $238 → $245 | Maintains | Overweight | |||
05/01/2024 | -8.22% | JP Morgan | $240 → $250 | Maintains | Overweight | |||
04/30/2024 | -10.06% | Barclays | $238 → $245 | Maintains | Overweight | |||
04/29/2024 | -8.22% | RBC Capital | $245 → $250 | Maintains | Outperform | |||
04/22/2024 | -12.63% | Alembic Global | → $238 | Upgrade | Neutral → Overweight | |||
02/13/2024 | -10.06% | Citigroup | $238 → $245 | Maintains | Buy | |||
01/30/2024 | -12.63% | Wells Fargo | $250 → $238 | Maintains | Overweight | |||
01/29/2024 | -10.06% | RBC Capital | $235 → $245 | Maintains | Outperform | |||
01/29/2024 | -15.93% | UBS | $222 → $229 | Maintains | Neutral | |||
01/29/2024 | -13.73% | Raymond James | $220 → $235 | Maintains | Outperform | |||
01/11/2024 | -11.89% | JP Morgan | → $240 | Upgrade | Neutral → Overweight | |||
12/15/2023 | -11.89% | Deutsche Bank | $184 → $240 | Upgrade | Hold → Buy | |||
12/14/2023 | -8.22% | Truist Securities | $224 → $250 | Maintains | Buy | |||
12/13/2023 | -17.4% | RBC Capital | $225 → $225 | Reiterates | Outperform → Outperform | |||
12/13/2023 | -19.24% | Raymond James | $210 → $220 | Maintains | Outperform | |||
12/07/2023 | -17.4% | RBC Capital | $225 → $225 | Reiterates | Outperform → Outperform | |||
11/29/2023 | -17.77% | Truist Securities | → $224 | Reiterates | Buy → Buy | |||
11/28/2023 | -15.57% | Wells Fargo | $211 → $230 | Maintains | Overweight | |||
10/31/2023 | -20.7% | Baird | $198 → $216 | Upgrade | Neutral → Outperform | |||
10/30/2023 | -17.4% | RBC Capital | $240 → $225 | Maintains | Outperform | |||
10/30/2023 | -22.91% | Raymond James | → $210 | Upgrade | Market Perform → Outperform | |||
10/20/2023 | -16.67% | Truist Securities | $255 → $227 | Maintains | Buy | |||
09/28/2023 | -29.52% | Deutsche Bank | → $192 | Initiates | → Hold | |||
09/18/2023 | -23.27% | Wells Fargo | $204 → $209 | Upgrade | Equal-Weight → Overweight | |||
09/11/2023 | -29.15% | Citigroup | → $193 | Reinstates | → Buy | |||
08/28/2023 | -22.91% | Bernstein | $239 → $210 | Downgrade | Outperform → Market Perform | |||
08/18/2023 | -11.89% | RBC Capital | → $240 | Reiterates | Outperform → Outperform | |||
08/02/2023 | -22.91% | B of A Securities | $230 → $210 | Maintains | Neutral | |||
07/31/2023 | -8.22% | Jefferies | $260 → $250 | Maintains | Buy | |||
07/28/2023 | -11.89% | RBC Capital | $250 → $240 | Maintains | Outperform | |||
07/28/2023 | -25.11% | Wells Fargo | $202 → $204 | Maintains | Equal-Weight | |||
05/01/2023 | -8.22% | RBC Capital | → $250 | Reiterates | → Outperform | |||
05/01/2023 | -18.5% | Baird | $241 → $222 | Maintains | Neutral | |||
05/01/2023 | -14.1% | Credit Suisse | $240 → $234 | Maintains | Outperform | |||
02/01/2023 | -15.57% | Wells Fargo | $219 → $230 | Maintains | Equal-Weight | |||
01/30/2023 | -3.08% | Morgan Stanley | $278 → $264 | Maintains | Overweight | |||
01/30/2023 | -6.39% | Truist Securities | $264 → $255 | Maintains | Buy | |||
01/30/2023 | -0.88% | Susquehanna | $265 → $270 | Maintains | Positive | |||
01/20/2023 | -11.89% | Credit Suisse | $244 → $240 | Maintains | Outperform | |||
01/12/2023 | -11.89% | Cowen & Co. | $260 → $240 | Maintains | Outperform | |||
01/11/2023 | -19.6% | Wells Fargo | $260 → $219 | Maintains | Equal-Weight | |||
12/19/2022 | -11.53% | Baird | $290 → $241 | Downgrade | Outperform → Neutral | |||
12/15/2022 | 2.06% | Morgan Stanley | $263 → $278 | Upgrade | Equal-Weight → Overweight | |||
12/12/2022 | -8.22% | JP Morgan | $260 → $250 | Maintains | Neutral | |||
11/11/2022 | -8.22% | B of A Securities | $285 → $250 | Downgrade | Buy → Neutral | |||
11/10/2022 | — | Argus Research | — | Downgrade | Buy → Hold | |||
11/10/2022 | -3.45% | Morgan Stanley | $276 → $263 | Maintains | Equal-Weight | |||
10/31/2022 | 6.46% | Baird | $332 → $290 | Maintains | Outperform |
L'ultimo obiettivo di prezzo per L3Harris Technologies (NYSE:LHX) è stato riportato da {{analyst} in data {{date}}. La società di analisi ha fissato un obiettivo di prezzo per $305.00 prevedendo che LHX raggiunga rise entro 12 mesi (un possibile 11.97% upside).
L'ultima valutazione degli analisti per L3Harris Technologies (NYSE:LHX) è stato fornita da Barclays e L3Harris Technologies mantenuto il suo rating overweight.
L'ultima revisione al rialzo di L3Harris Technologies Inc è avvenuta il aprile 11, 2025, quando Goldman Sachs ha alzato il suo obiettivo di prezzo a $263. In precedenza Goldman Sachs aveva a sell per L3Harris Technologies Inc.
L'ultima revisione al ribasso di L3Harris Technologies Inc si è verificata il gennaio 2, 2025, quando Raymond James ha modificato il suo obiettivo di prezzo da N/A a N/A per L3Harris Technologies Inc.
Gli analisti giungono alle valutazioni dei titoli dopo aver fatto ricerche approfondite, che comprendono l'esame dei bilanci pubblici, i colloqui con i dirigenti e i clienti di L3Harris Technologies e l'ascolto delle comunicazioni degli utili. La maggior parte degli analisti svolge questa attività ogni tre mesi, quindi dovresti ricevere 4 valutazioni all'anno per azienda e per società. L'ultima valutazione di L3Harris Technologies è stata depositata il luglio 29, 2025, quindi dovresti aspettarti che la prossima valutazione sia disponibile intorno a luglio 29, 2026.
Sebbene le valutazioni siano soggettive e possano cambiare, l'ultima valutazione di L3Harris Technologies (LHX) è stata una mantenuto con un obiettivo di prezzo di $255.00 a $305.00. Il prezzo attuale a cui L3Harris Technologies (LHX) è scambiato è $272.40, che è within del range previsto dall'analista.
Sfoglia valutazioni degli analisti e obiettivi di prezzo su tutte le azioni.